Transforming psychedelic research into cutting edge medicine
Ceruvia Lifesciences researches, develops, and manufactures neurotransformational medicines to address challenging hard-to-treat disorders, such as headache disorders and Obsessive Compulsive Disorder (OCD)
Sign up to Download our Corporate Presentation
Addressing poorly understood disorders with new alternative therapies, research, and development
Headache Disorders
Reducing the frequency and severity of headache attacks
Obsessive Compulsive Disorder
Providing meaningful symptom reduction
Research and Development
Discovering novel neurotransformational medicines
About Ceruvia Lifesciences
Patient populations suffering from headache disorders and Obsessive Compulsive Disorder have few medical alternatives and continue to have their medical needs unmet.
At Ceruvia Lifesciences, we discover and manufacture neurotransformational medicines in order to help return these overlooked groups to living their lives to the fullest.
Ceruvia Lifesciences’ foundation of established collaborations with leading institutions, renowned key stakeholders in headache disorders and psychedelic research, and a leadership team and scientific advisors steeped in experience drives Ceruvia Lifesciences’ mission to deliver value in breakthrough treatments to this overlooked market.
We are the world’s first producers of GMP LSD, which we supply to academic research sites, and GMP BOL-148.
We are thrilled to be in a position to be able to provide funding to seek out relief for those suffering from a variety of painful neurological conditions.
~Carey and Claudia Turnbull, The Turnbull Family Foundation
